跳到主要內容

Catalyst4, Inc. 的 Form 4 申報

MapLight Therapeutics, Inc.(MPLT),2025/10/29 申報

申報編號
0001900201-25-000008
申報時間
2025/10/29
交易日
2025/10/28
申報延遲
1 天
10b5-1 計畫
沒有勾選

這份申報列了 2 筆非衍生性交易、6 筆衍生性交易。公開市場買進合計 $9,250 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Catalyst4, Inc.CIK 0001900201持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/10/28Voting Common StockC轉換取得+14,256,288–F1–14,256,288間接
2025/10/28Voting Common StockP買進取得+5,441,176$17.00+$92,499,99219,697,464間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2025/10/28Voting Common StockC轉換處分−148,809–F3–0間接
2025/10/28Voting Common StockC轉換處分−444,846–F4–0間接
2025/10/28Voting Common StockC轉換處分−1,263,768–F5–0間接
2025/10/28Voting Common StockC轉換處分−275,148–F6–0間接
2025/10/28Voting Common StockC轉換處分−5,444,807–F7–0間接
2025/10/28Voting Common StockC轉換處分−6,678,910–F8–0間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The Series A, A-1, B, B-1, C and D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 I 有 1 筆交易的價格引用這則附註。

F3

The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

F4

The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

F5

The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

F6

The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

F7

The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

F8

The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

表 II 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)